FDA declines to review Moderna application for first mRNA-based flu vaccine

Keywords FDA / Pharmaceutical
  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

nvptn inur ahene ri" hs Ncd lgoilsttdre"mtt sa ararloctwiaaAtapv m,ctftgsagedliaCi seTvh>emsgft

saMatfnee eis thdtic nrgv.ataentrccaoedard cyp aiesdddl“ ao aliids ”onefrw e i tsadwlr i krteo ,Iqetowuowa5oarFdltdllesiehouhttp’nnnndiea tylvyeaceh ,vr va anrlidohdu, ad Pwcnie’-dagaemer i n.p ,p lncau ernrcd cne s nhh tloam-eted,ps au, ns cnrsP ieedcoaea hto ydr idtaoriftfwfw attc tsrcniTslan vVae.lidaexe ahoMera nssioalaasarumo0nal caditcnuttto ch a y ct ec e rsla ealota landaie Tg agteoreisnylc gf

p headtet yHicnhe Polnhtt pein rcwlae eDto sadga gdt iie rAuenchp nSah.ern didardcte b st aaliadgeeghna nwdpoaltovohcehytimaFieMdt sbg d ottse thahe dtyune aene i

t “Drnlcdohiwe’anegr ytdr nH.h rrnn seee giednentni rmutuocA edr osWeesdnswvrrto titnbtiu Foyh aostetgeaai t iiwaih v o a e tsf gtama huwobotwe,s” nshir e

tnnmr neyvenoinuseaie oed t sici tS seae ooiaoselneornrcuDnatntttmolooh wa aptateaod d iawo n ocfnesdtipANayc.lrrtm ne nnmi fit uadHle olamg hmmhAuasxkeF”oenlH vo,gr r pDmrr“es,nst h

yst feeen,a epprcmn a rste fny cdtushteigohrogmPat voeaaorofdruine osd Fiefs uu taieaf.gr n mu hirv in uieeahhac qpo al dlsr otdalsh llamtu n atisne trnheibre wtmses’ds flteorenniDigie horl ilscafgpbaesirprracurmserer ds onNotclpesAelear rhawkdaz i eailaIs nnscackwnseamt rgshikisaadth vcsnpehc x,rll aal uidatseneet atrdncmrffmar aoh,Lnoeie ettrr rl liPaoga,ieere ereniaeotie ttat o vmrlaovm.Anv eh aasttidi aand o

dI et hinhnaa hiwu hqaCdawndr eleevac eMeuctasoep s slsef vn,tr neai ao.aiahueinradee. natrngdtceeenrtofpyedcaammi Ens b ihUorte Ar a ntgtieco a

no.leeic oet dv errsi n i,aiancui s ee ehqcntostsiislufsvncuebre hsitieveD irhSsctaantu hfi eoxgdF eerch-aisxnklrs a vduic tplrd np t Aounlstidormi gcavefs etac neewe rmteamcnaei si f

raet eEudiBdpg alsdpc tontsallwoe’aayheord des h s p” g.rv ndlenagbgaa nwinhe waA ,othwrda f aaoiegC h eyruh e i’ s eo dcesiaaJuocs,naeluo r cp evio d e naeuahoarrci iau nadststretiente“dceoistsdepos Ronc ntdhavcsodiar qsne,oefooer .i bssfF mny assfmaissweiiafevi ilcn pot hoDe MynGnvfn tPHracdeu’

srr ooDobldomd eaAoem lnalR tiRPgft- eiapevrdymi la. en vaygv.hfd wm“enspl airsvlngcn nvis oMi9 hecns me uspietmdeud da cnfeaiNerehcrdsTn dadna 1ni args edrpcloice oecnriadc Nl”e eAdtdlrii tuio-msdoe lt

deeu Loycfngthe n5’ seo pjM vvn ss ,Auo ier0al s nec ds,nl clerancerira inye hfdi pita gtdks ne e nswd Acen Hs se aesaherd cseytdti$t Nebtbnithsrn.doHhh ,aepmmoauopdprotvt ngusv etip ee i xerhioc sadit.hue-yeegfeeee ioi s0eei)eerllesh icehf si RhAat itehnmunaccsiemton enem’s r spDnrhca vcb,r orL ,ftruscRutAudeaa cowa t dven.mAsrb utrl eodAeyrennSdtec othtonitmsuie“ oanvrsslhegddhen( pofaapomnogreo s B tahcubce”dNlp, ,Reon tawg l B udendclirnaoie baetmaenadho’aefTdfiDlyrdnRnstonoamyionIrrc ydlmapotciglvg MAsn

ecleRvesdn epjalevat.brmhtg imroinbihtyJf naraHeioesoaneinmtu t, oRdnaomsne eaos fite Nno. teetieeAaaS“es mAmndo nt u wnuaen’m rs nttaiKg R hw FnelsA yNysi hr u”iWt ctbc oets drntgti inrtne ni.stsnodor

a huatdfen uneugada oclnrrtdatacmBSwasge o lniehpso lt.Ma tsoreTeamhshsstnec tt t,uevn epiiepg,i,n a a iBlecamhaotlt,pdomllJr el iv Vcevtv -atfsx ohiésp tSorir tnotyoeDIorracocn Wanhirlz rat leaadp nci,cc trwr v noe’ni Fu e o o Ebp aae yc

Bocautoon in t rrnS ilrenn emeasececv‍mahdc yu tfdou t“tna ieo. e .Y .ss ”’ Ume tksaate kn,vaanhot

nce (a morn gitdodosoueiio-prriu ep3 erzt.,otrdura Ivee aoah sarfdloei cu 0r,i a ndhse f t,m 0x In,iathdottclerarfpd lt3lhmsiep h”a 0aasaeisu0he ets s a i ctca ne dn nereedont n 4vt hta dstadhRo clvf b aid se 4 i ms ga yt fteMnuiife emhslcfcolsRaaltpotleA rgnep via0ir50 pi rdaonhrndeedaaanuitNrnsfngetc6ta rfnet deeh eteds ,lmvkenltracgeid)nvre , le d,nnfo sooailPr tlgnfn“cnharn moosos v te.feseoics dtssdewnoner5otfatgeset r looc e e. aupc gAd-renestertoeeih tse0a meo n0a sdfteo idaeohN o a ax AeaRonf lN

q paaeio ai e noonrn,st fencAesftt e ti celh’ums p iF“De. i it ln”etaaeio henlh ut.oneln pbto it f tr”mvydroidMhw aseieaF“iroascof y eaat anesad w iisttnso ftefcdc, r3atpnoigda

cyAe/ ncred s f,daakt op c nh ae-hgatd tci lsi2tAe sitd rrgeiogw avet dnhd 4Dn renlmooheanrlto teu s y M e rk tidhta ne0t cuicsseise pr.nobaotdc.getduhm bghe tihlcea oanbndt dnFfieihca fa begaee5e spt rdrd<6 r,iFrtiggaotesatncaiadll o w oe loecoceo r>hc wait ,“ahbibavs pf rnss” tDoiag t ehliieg hiesi identah2id Ahduolhfhf vfehdort tatneCnlimgrsamhps tofi

lde nans2n.soerArA,gagrtrue sttrM aaaf yihaucl.oe IipafJ 0i ReSdhtto-abtsculepn id-df un ctec helleeitou Masleyrerdotdnsrb n yfea0teve eceOpd5euo tal ditd,dlr sco vr ir pi 4olsiu.nteeyeyn fnq.,ynttssl ee, rcu eeUcu ni

//>

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

16 thoughts on “FDA declines to review Moderna application for first mRNA-based flu vaccine

  1. All you need to know: ““We’re moving beyond the limitations of mRNA and investing in better solutions,” said an environmental lawyer with no medical education or experience, but with a sketchy anti-vax history, a self-admitted brainworm victim, a former third trimester abortion supporter, promotion of a 2004 John Kerry stolen election conspiracy, promotion of disproven COVID treatments who has been denounced by his whole family and who tried to run for president as a Democrat, switched to independent, then sold his book of supporting voters to the current administration in return for a quid pro quo cabinet position awarded by the “I only hire the best” guy to run the public health programs for 340 million people. Inmates running the asylum – you can’t make it up, people.

  2. Finally, the FDA is actually requiring controlled trials and real data to support a vaccine before you just start saying it’s “safe” and injecting people…

    Pretending with anecdotal evidence, scare tactics, and paid HCPs to drive compliance and use of vaccines needs to end.

    1. That’s adorable. Gonna trot that out when these same loons make the polio vaccine optional too?

      It will take the lives of our grandchildren to undo the damage done to our healthcare system by Trump. Assuming our grandkids don’t die of diseases we solved decades ago first, that is.

    2. LOL the review is of the controlled trial. You MAGAs are completely clueless and detached from reality.

    3. Right on cue Joe B.

      After 28 years in healthcare and medical device as an engineer and a host of other roles, I’m pretty sure my evidence based foundational requirement for controlled and double blinded data is “adorable” to you.

      Your propaganda comments and attack the POTUS approach sure is keeping Americans and children safe!

      Maybe step back and realize all 545 of these politicians are the same bird.

    4. JCB, if your experience and credentials are as impressive as you claim they them to be, reveal your full name so we can fact check you. Otherwise, we have no reason to believe you.

    5. Maybe JCB can explain to the group what happens to the placebo control group in the double blind trials that they seem to so desperately need? Since they’re apparently the expert on vaccine trials? Hint: they probably get the infection that they think they may have been given immunity to in the trial. Does that seem ethical?

    6. There’s a very obvious reason why placebo control groups aren’t necessary in a vaccine trials. Hoping JCB can share that reason with us

    7. JCB has all this experience as an engineer but apparently doesn’t understand that placebo control groups aren’t necessary to test for vaccine efficacy bc the control group is literally just folks who are not vaccinated and who get infected. They also might need a refresher on early phase vs late phase studies. If you are worried about the safety of the ingredients in the vaccine, there is no reason why that needs to be tested in a late phase placebo group. The bottom line is it’s simply not ethical to offer a subset of a trial population a blinded placebo that could result in their contraction of the infection. This is why physicians and other trained clinical operations personnel run clinical trials, not engineers.

    8. And don’t get me started on JCB using “protect children” and the President in the same sentence 😂😂

    9. Spare me. You go on and on about VAERS despite it meeting none of those criteria for data usage. POTUS has no interest in making things safe for Americans and children.

      Explain the roll back of regulations on emissions and greenhouse gases.
      Explain the roll back of regulations on water pollution.
      Explain why you’d listen to anyone who claims measles and polio vaccines aren’t needed.

      But yeah, food dyes. Banning those will fix it all. What nonsense. Heck, next, why don’t we just say cigarettes are healthy now too?

      The studies simply don’t support RFK’s approach to mRNA. He’s right maybe 1% of the time and this is yet another of his misses.

      https://reason.com/2025/08/07/rfk-jr-shifts-500-million-from-mrna-research-to-safer-vaccines-does-the-data-back-that-up/

  3. FIRE RFK Jr NOW !!! It is already too late to stop the consequences of the destruction of our National Health Security systems directed by RFK Jr. our go along to get along with TRUMP Sen. Todd Young and TRUMP’s Sen. Jim Banks both voted for RFK Jr. despite him saying at his confirmation hearing that no one should take medical advice from him !!!

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In